Immunitybio Stock Technical Analysis
| IBRX Stock | USD 5.95 0.67 10.12% |
As of the 15th of February 2026, Immunitybio retains the Risk Adjusted Performance of 0.1898, market risk adjusted performance of 3.2, and Downside Deviation of 4.98. Immunitybio technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Immunitybio Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Immunitybio, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ImmunitybioImmunitybio | Build AI portfolio with Immunitybio Stock |
Immunitybio Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 11.8 | Strong Buy | 5 | Odds |
Most Immunitybio analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Immunitybio stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Immunitybio, talking to its executives and customers, or listening to Immunitybio conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunitybio. Market participants price Immunitybio higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Immunitybio assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Immunitybio requires distinguishing between market price and book value, where the latter reflects Immunitybio's accounting equity. The concept of intrinsic value - what Immunitybio's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Immunitybio's price substantially above or below its fundamental value.
Please note, there is a significant difference between Immunitybio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunitybio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Immunitybio's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Immunitybio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immunitybio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immunitybio.
| 11/17/2025 |
| 02/15/2026 |
If you would invest 0.00 in Immunitybio on November 17, 2025 and sell it all today you would earn a total of 0.00 from holding Immunitybio or generate 0.0% return on investment in Immunitybio over 90 days. Immunitybio is related to or competes with Arcus Biosciences, Denali Therapeutics, Cogent Biosciences, Galapagos, Beam Therapeutics, Recursion Pharmaceuticals, and Liquidia Technologies. ImmunityBio, Inc., a clinical-stage biotechnology company, engages in developing therapies and vaccines that complement,... More
Immunitybio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immunitybio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immunitybio upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.98 | |||
| Information Ratio | 0.2155 | |||
| Maximum Drawdown | 51.87 | |||
| Value At Risk | (7.49) | |||
| Potential Upside | 14.55 |
Immunitybio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immunitybio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immunitybio's standard deviation. In reality, there are many statistical measures that can use Immunitybio historical prices to predict the future Immunitybio's volatility.| Risk Adjusted Performance | 0.1898 | |||
| Jensen Alpha | 1.8 | |||
| Total Risk Alpha | 1.22 | |||
| Sortino Ratio | 0.3565 | |||
| Treynor Ratio | 3.19 |
Immunitybio February 15, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1898 | |||
| Market Risk Adjusted Performance | 3.2 | |||
| Mean Deviation | 5.48 | |||
| Semi Deviation | 4.41 | |||
| Downside Deviation | 4.98 | |||
| Coefficient Of Variation | 446.36 | |||
| Standard Deviation | 8.24 | |||
| Variance | 67.91 | |||
| Information Ratio | 0.2155 | |||
| Jensen Alpha | 1.8 | |||
| Total Risk Alpha | 1.22 | |||
| Sortino Ratio | 0.3565 | |||
| Treynor Ratio | 3.19 | |||
| Maximum Drawdown | 51.87 | |||
| Value At Risk | (7.49) | |||
| Potential Upside | 14.55 | |||
| Downside Variance | 24.83 | |||
| Semi Variance | 19.42 | |||
| Expected Short fall | (7.30) | |||
| Skewness | 2.17 | |||
| Kurtosis | 7.77 |
Immunitybio Backtested Returns
Immunitybio is unstable given 3 months investment horizon. Immunitybio holds Efficiency (Sharpe) Ratio of 0.24, which attests that the entity had a 0.24 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.06% are justified by taking the suggested risk. Use Immunitybio Market Risk Adjusted Performance of 3.2, downside deviation of 4.98, and Risk Adjusted Performance of 0.1898 to evaluate company specific risk that cannot be diversified away. Immunitybio holds a performance score of 19 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 0.58, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Immunitybio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Immunitybio is expected to be smaller as well. Use Immunitybio maximum drawdown, as well as the relationship between the skewness and day typical price , to analyze future returns on Immunitybio.
Auto-correlation | 0.24 |
Weak predictability
Immunitybio has weak predictability. Overlapping area represents the amount of predictability between Immunitybio time series from 17th of November 2025 to 1st of January 2026 and 1st of January 2026 to 15th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immunitybio price movement. The serial correlation of 0.24 indicates that over 24.0% of current Immunitybio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.24 | |
| Spearman Rank Test | 0.04 | |
| Residual Average | 0.0 | |
| Price Variance | 3.28 |
Immunitybio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Immunitybio Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Immunitybio across different markets.
About Immunitybio Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Immunitybio on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Immunitybio based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Immunitybio price pattern first instead of the macroeconomic environment surrounding Immunitybio. By analyzing Immunitybio's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Immunitybio's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Immunitybio specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Interest Debt Per Share | 1.6 | 0.91 | 0.82 | 0.47 | Revenue Per Share | 0.001223 | 0.0211 | 0.019 | 0.02 |
Immunitybio February 15, 2026 Technical Indicators
Most technical analysis of Immunitybio help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Immunitybio from various momentum indicators to cycle indicators. When you analyze Immunitybio charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1898 | |||
| Market Risk Adjusted Performance | 3.2 | |||
| Mean Deviation | 5.48 | |||
| Semi Deviation | 4.41 | |||
| Downside Deviation | 4.98 | |||
| Coefficient Of Variation | 446.36 | |||
| Standard Deviation | 8.24 | |||
| Variance | 67.91 | |||
| Information Ratio | 0.2155 | |||
| Jensen Alpha | 1.8 | |||
| Total Risk Alpha | 1.22 | |||
| Sortino Ratio | 0.3565 | |||
| Treynor Ratio | 3.19 | |||
| Maximum Drawdown | 51.87 | |||
| Value At Risk | (7.49) | |||
| Potential Upside | 14.55 | |||
| Downside Variance | 24.83 | |||
| Semi Variance | 19.42 | |||
| Expected Short fall | (7.30) | |||
| Skewness | 2.17 | |||
| Kurtosis | 7.77 |
Immunitybio February 15, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Immunitybio stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.19 | ||
| Daily Balance Of Power | (0.49) | ||
| Rate Of Daily Change | 0.90 | ||
| Day Median Price | 6.62 | ||
| Day Typical Price | 6.40 | ||
| Price Action Indicator | (1.00) | ||
| Market Facilitation Index | 1.36 |
Additional Tools for Immunitybio Stock Analysis
When running Immunitybio's price analysis, check to measure Immunitybio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunitybio is operating at the current time. Most of Immunitybio's value examination focuses on studying past and present price action to predict the probability of Immunitybio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunitybio's price. Additionally, you may evaluate how the addition of Immunitybio to your portfolios can decrease your overall portfolio volatility.